99 related articles for article (PubMed ID: 11256579)
1. Expression databases--resources for pharmacogenomic R&D.
Furness LM; Henrichwark S; Egerton M
Pharmacogenomics; 2000 Aug; 1(3):281-8. PubMed ID: 11256579
[TBL] [Abstract][Full Text] [Related]
2. Gene expression analysis as an aid to the identification of drug targets.
Zanders ED
Pharmacogenomics; 2000 Nov; 1(4):375-84. PubMed ID: 11257923
[TBL] [Abstract][Full Text] [Related]
3. PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics.
Owen RP; Altman RB; Klein TE
Hum Mutat; 2008 Apr; 29(4):456-60. PubMed ID: 18330919
[TBL] [Abstract][Full Text] [Related]
4. Systems toxicology and the Chemical Effects in Biological Systems (CEBS) knowledge base.
Waters M; Boorman G; Bushel P; Cunningham M; Irwin R; Merrick A; Olden K; Paules R; Selkirk J; Stasiewicz S; Weis B; Van Houten B; Walker N; Tennant R
EHP Toxicogenomics; 2003 Jan; 111(1T):15-28. PubMed ID: 12735106
[TBL] [Abstract][Full Text] [Related]
5. Application of the DruGeVar Database in Cancer Genomics and Pharmacogenomics.
Sarris K; Komianou A; Patrinos GP; Katsila T
Public Health Genomics; 2017; 20(2):142-147. PubMed ID: 28704821
[TBL] [Abstract][Full Text] [Related]
6. Clinical Data restructures to emphasize core pharmacogenomics and metabolomics business.
Pharmacogenomics; 2006 Mar; 7(2):148. PubMed ID: 16552914
[No Abstract] [Full Text] [Related]
7. Pharmacogenomic analysis: correlating molecular substructure classes with microarray gene expression data.
Blower PE; Yang C; Fligner MA; Verducci JS; Yu L; Richman S; Weinstein JN
Pharmacogenomics J; 2002; 2(4):259-71. PubMed ID: 12196914
[TBL] [Abstract][Full Text] [Related]
8. PharmGKB: the pharmacogenetics and pharmacogenomics knowledge base.
Thorn CF; Klein TE; Altman RB
Methods Mol Biol; 2005; 311():179-91. PubMed ID: 16100408
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomic data sample collection and storage: ethical issues and policy approaches.
Joly Y; Knoppers BM
Pharmacogenomics; 2006 Mar; 7(2):219-26. PubMed ID: 16515401
[TBL] [Abstract][Full Text] [Related]
10. Single cell expression analysis--pharmacogenomic potential.
Dixon AK; Lee K; Richardson PJ; Bell MI; Skynner MJ
Pharmacogenomics; 2002 Nov; 3(6):809-22. PubMed ID: 12437482
[TBL] [Abstract][Full Text] [Related]
11. Genomics and large scale phenotypic databases.
Winkelmann BR
Pharmacogenomics; 2001 Feb; 2(1):3-5. PubMed ID: 11258195
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomic agreement between two cancer cell line data sets.
;
Nature; 2015 Dec; 528(7580):84-7. PubMed ID: 26570998
[TBL] [Abstract][Full Text] [Related]
13. Analysis of pharmacokinetics, pharmacodynamics, and pharmacogenomics data sets using VizStruct, a novel multidimensional visualization technique.
Bhasi K; Zhang L; Zhang A; Ramanathan M
Pharm Res; 2004 May; 21(5):777-80. PubMed ID: 15180333
[TBL] [Abstract][Full Text] [Related]
14. Genetics for the pediatric anesthesiologist: a primer on congenital malformations, pharmacogenetics, and proteomics.
Galinkin JL; Demmer L; Yaster M
Anesth Analg; 2010 Nov; 111(5):1264-74. PubMed ID: 20841405
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of popular drug information resources on clinically useful and actionable pharmacogenomic information.
Chang JS; Pham DA; Dang MT; Lu Y; VanOsdol S; Shin J
J Med Libr Assoc; 2016 Jan; 104(1):58-61. PubMed ID: 26807054
[TBL] [Abstract][Full Text] [Related]
16. Exploratory visual analysis of pharmacogenomic results.
Reif DM; Dudek SM; Shaffer CM; Wang J; Moore JH
Pac Symp Biocomput; 2005; ():296-307. PubMed ID: 15759635
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA pharmacogenomics: post-transcriptional regulation of drug response.
Rukov JL; Shomron N
Trends Mol Med; 2011 Aug; 17(8):412-23. PubMed ID: 21652264
[TBL] [Abstract][Full Text] [Related]
18. Multifactor dimensionality reduction for detecting gene-gene and gene-environment interactions in pharmacogenomics studies.
Ritchie MD; Motsinger AA
Pharmacogenomics; 2005 Dec; 6(8):823-34. PubMed ID: 16296945
[TBL] [Abstract][Full Text] [Related]
19. The use of single-nucleotide polymorphism maps in pharmacogenomics.
McCarthy JJ; Hilfiker R
Nat Biotechnol; 2000 May; 18(5):505-8. PubMed ID: 10802616
[TBL] [Abstract][Full Text] [Related]
20. Cambridge Healthtech Institute's 2nd Annual Conference on Pharmacogenomics Europe: presaging profits.
Kerb R; Brinkmann U
Pharmacogenomics; 2001 Aug; 2(3):303-5. PubMed ID: 11939136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
